The global single-use bioreactors market size accounted for USD 6.12 billion in 2024, grew to USD 7.26 billion in 2025 and is predicted to surpass around USD 33.70 billion by 2034, representing a healthy CAGR of 18.60% between 2024 and 2034. The North America single-use bioreactors market size is calculated at USD 1.96 billion in 2024 and is expected to grow at a fastest CAGR of 18.77% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Single-use Bioreactors Market, by Product, 2024-2034
7.1.1. Single-use Bioreactor Systems
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Single-use Media Bags
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. Single-use Filtration Assemblies
7.1.3.1. Market Revenue and Forecast (2021-2034)
7.1.4. Other Products
7.1.4.1. Market Revenue and Forecast (2021-2034)
8.1. Single-use Bioreactors Market, by Type, 2024-2034
8.1.1. Stirred-tank SUBs
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Bubble-column SUBs
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Wave-induced SUBs
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Other SUBs
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Single-use Bioreactors Market, by Type of Cell, 2024-2034
9.1.1. Mammalian Cells
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Yeast Cells
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Bacterial Cells
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Single-use Bioreactors Market, by Molecule Type, 2024-2034
10.1.1. Monoclonal Antibodies
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Vaccines
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Stem Cells
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Gene Modified Cells
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2021-2034)
11.1. Single-use Bioreactors Market, by Application, 2024-2034
11.1.1. Research and Development (R&D) or Process Development
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Bioproduction
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Single-use Bioreactors Market, by End-Use, 2024-2034
12.1.1. CROs & CMOs
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Pharmaceutical & Biopharmaceutical Companies
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Academic & Research Institutes
12.1.3.1. Market Revenue and Forecast (2021-2034)
13.1. Single-use Bioreactors Market, by Usage Type, 2024-2034
13.1.1. Pilot-scale Production
13.1.1.1. Market Revenue and Forecast (2021-2034)
13.1.2. Lab-scale Production
13.1.2.1. Market Revenue and Forecast (2021-2034)
13.1.3. Large-scale Production
13.1.3.1. Market Revenue and Forecast (2021-2034)
14.1. North America
14.1.1. Market Revenue and Forecast, by Product (2021-2034)
14.1.2. Market Revenue and Forecast, by Type (2021-2034)
14.1.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.1.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.1.5. Market Revenue and Forecast, by Application (2021-2034)
14.1.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.1.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Product (2021-2034)
14.1.8.2. Market Revenue and Forecast, by Type (2021-2034)
14.1.8.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.1.8.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.1.8.5. Market Revenue and Forecast, by Application (2021-2034)
14.1.8.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.1.8.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product (2021-2034)
14.1.9.2. Market Revenue and Forecast, by Type (2021-2034)
14.1.9.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.1.9.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.1.9.5. Market Revenue and Forecast, by Application (2021-2034)
14.1.9.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.1.9.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product (2021-2034)
14.2.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.2.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.2.5. Market Revenue and Forecast, by Application (2021-2034)
14.2.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.2.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product (2021-2034)
14.2.8.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.8.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.2.8.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.2.8.5. Market Revenue and Forecast, by Application (2021-2034)
14.2.8.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.2.8.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Product (2021-2034)
14.2.9.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.9.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.2.9.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.2.9.5. Market Revenue and Forecast, by Application (2021-2034)
14.2.9.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.2.9.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Product (2021-2034)
14.2.10.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.10.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.2.10.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.2.10.5. Market Revenue and Forecast, by Application (2021-2034)
14.2.10.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.2.10.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Product (2021-2034)
14.2.11.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.11.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.2.11.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.2.11.5. Market Revenue and Forecast, by Application (2021-2034)
14.2.11.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.2.11.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product (2021-2034)
14.3.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.3.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.3.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.3.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
14.3.8.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.8.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.3.8.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.3.8.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.8.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.3.8.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Product (2021-2034)
14.3.9.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.9.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.3.9.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.3.9.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.9.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.3.9.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Product (2021-2034)
14.3.10.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.10.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.3.10.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.3.10.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.10.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.3.10.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Product (2021-2034)
14.3.11.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.11.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.3.11.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.3.11.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.11.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.3.11.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product (2021-2034)
14.4.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.4.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.4.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.4.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
14.4.8.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.8.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.4.8.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.4.8.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.8.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.4.8.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Product (2021-2034)
14.4.9.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.9.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.4.9.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.4.9.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.9.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.4.9.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Product (2021-2034)
14.4.10.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.10.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.4.10.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.4.10.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.10.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.4.10.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Product (2021-2034)
14.4.11.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.11.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.4.11.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.4.11.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.11.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.4.11.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product (2021-2034)
14.5.2. Market Revenue and Forecast, by Type (2021-2034)
14.5.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.5.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.5.5. Market Revenue and Forecast, by Application (2021-2034)
14.5.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.5.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Product (2021-2034)
14.5.8.2. Market Revenue and Forecast, by Type (2021-2034)
14.5.8.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.5.8.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.5.8.5. Market Revenue and Forecast, by Application (2021-2034)
14.5.8.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.5.8.7. Market Revenue and Forecast, by End-Use (2021-2034)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product (2021-2034)
14.5.9.2. Market Revenue and Forecast, by Type (2021-2034)
14.5.9.3. Market Revenue and Forecast, by Type of Cell (2021-2034)
14.5.9.4. Market Revenue and Forecast, by Molecule Type (2021-2034)
14.5.9.5. Market Revenue and Forecast, by Application (2021-2034)
14.5.9.6. Market Revenue and Forecast, by Usage Type (2021-2034)
14.5.9.7. Market Revenue and Forecast, by End-Use (2021-2034)
15.1. ABEC Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Able Corporation & Biott Corporation (Japan)
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Applikon Biotechnology B.V.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Aptus bioreactors.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5 Cell culture company
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Cellexus Ltd
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Celltainer Biotech BV (Netherlands)
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. CESCO Bioengineering Co., Ltd.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Danaher Corporation
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Distek Inc. (US)
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample